ADRB2 and prostate carcinoma: We also demonstrated that β2AR-HIF-1α-CXCL12 of osteoblasts triggered by ISO contributed to migration and invasion of prostate cancer cells, which could be inhibited by the β2AR-blockers ICI118,551 and CXCR4 inhibitor LY2510924.